Home page601607 • SHA
add
Shanghai Pharmaceuticals Holding Ord Shs A
Chiusura precedente
17,14 ¥
Intervallo giornaliero
16,96 ¥ - 17,14 ¥
Intervallo annuale
16,23 ¥ - 19,68 ¥
Cap di mercato
56,72Â Mld CNY
Volume medio
11,00Â Mln
Rapporto P/E
11,01
Dividendo/Prezzo
-
Borsa valori principale
SHA
Notizie del mercato finanziario
NDAQ
0,29%
1,29%
1,20%
1,79%
Dati finanziari
Conto economico
Entrate
Utile netto
| (CNY) | dic 2025info | Variazione Y/Y |
|---|---|---|
Entrate | 68,51Â Mld | 4,40% |
Spese di gestione | 5,91Â Mld | 14,38% |
Utile netto | 577,49Â Mln | 15,88% |
Margine di profitto netto | 0,84 | 10,53% |
Utili per azione | — | — |
EBITDA | 2,54Â Mld | 1,86% |
Aliquota fiscale effettiva | 35,10% | — |
Stato patrimoniale
Totale attivo
Totale passivo
| (CNY) | dic 2025info | Variazione Y/Y |
|---|---|---|
Investimenti cash/breve termine | 43,08Â Mld | -2,92% |
Totale attivo | 233,15Â Mld | 5,40% |
Totale passivo | 143,36Â Mld | 4,29% |
Patrimonio netto totale | 89,79 Mld | — |
Azioni in circolazione | 3,71 Mld | — |
Prezzo/valore contabile | 0,84 | — |
Rendimento delle attività | 2,17% | — |
Rendimento sul capitale | 3,45% | — |
Flusso di cassa
Flusso di cassa netto
| (CNY) | dic 2025info | Variazione Y/Y |
|---|---|---|
Utile netto | 577,49Â Mln | 15,88% |
Liquidità di esercizio | 3,80 Mld | 24,97% |
Liquidità da investimenti | -3,19 Mld | -5.603,51% |
Liquidità da finanziamenti | -5,10 Mld | -154,82% |
Flusso di cassa netto | -4,48Â Mld | -497,41% |
Flusso di cassa libero | 3,28Â Mld | -40,43% |
Informazioni
Shanghai Pharmaceuticals is a private-sector Chinese pharmaceutical company. The organization develops and distributes pharmaceutical products and operates in domestic and international markets.
Shanghai Pharma is the largest pharmaceutical and the first A+H listed company in China to be dual-listed by Shanghai and Hong Kong Stock Exchanges. As of 2020, the company made its presence to the Global Fortune 500 list with the ranking of 473, overall and 124 among 21 other Chinese companies on the list.
Shanghai Pharmaceuticals was founded in 1994 and is headquartered in Shanghai. As an investment holding company, it is actively engaged in research, manufacturing and distribution of pharmaceutical and healthcare products in China, that develops and distributes traditional Chinese and chemical drugs, chemical, biochemical and healthcare goods that are applied in various therapeutic fields, including immunoregulation and anti-cancer, immune system and digestion, cardiovascular and anti-infection, nervous system and mental disorder. Wikipedia
Fondazione
18 gen 1994
Sito web
Dipendenti
49.608